Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Chirantan Chatterjee

Biographic Data

ID3927019
NAMEChirantan Chatterjee
GIVEN NAMESChirantan
FAMILY NAMEChatterjee
SIGNATURECHATTERJEE C
AFFILIATIONSIndian Institute of Management Bangalore
ORCID0000-0002-4684-2858
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS11
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2016
LATEST PUBLICATION YEAR2024
H-INDEX2
  • Did the Covid-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data

    Open Access•Sawan Rathi, Adrija Majumdar et al.•ARTICLE•Technological Forecasting and…•2024

    It is now much discussed that Artificial Intelligence (AI) as a General-Purpose Technology (GPT) can resolve the efficiency problems of industries, including in pharmaceutical markets where productivity challenges continue in costs and time for new drug discovery. But did the COVID-19 pandemic inadvertently accelerate the pace of AI adoption in pharmaceutical innovation? We answer this question using novel data on pharmaceutical patents. We use t…

  • Women’s Disempowerment and Preferences for Skin Lightening Products That Reinforce Colorism

    Open Access•Arzi Adbi, Chirantan Chatterjee et al.•ARTICLE•Psychology of Women Quarterly•2021•Cited by: 6•References: 15

    Global racism and colorism, the preference for fairer skin even within ethnic and racial groups, leads millions of women of African, Asian, and Latin descent to use products with chemical ingredients intended to lighten skin color. Drawing from literatures on the impact of chronic and situational disempowerment on behavioral risk-taking to enhance status, we hypothesized that activating feelings of disempowerment would increase women of color’s i…

  • Intellectual property regimes and wage inequality

    Open Access•Sourav Bhattacharya, Pavel Chakraborty et al.•ARTICLE•Journal of Development Economics•2021•Cited by: 1•References: 8

  • Did India's price control policy for coronary stents create unintended consequences

    Open Access•Sarang Deo, Hanu Tyagi et al.•ARTICLE•Social Science & Medicine•2020•References: 24

  • From courts to markets

    Open Access•Chirantan Chatterjee, Debi Prasad Mohapatra et al.•ARTICLE•Social Science & Medicine•2019•Cited by: 1•References: 25

  • Government health insurance and spatial peer effects

    Open Access•Chirantan Chatterjee, Radhika Joshi et al.•ARTICLE•Social Science & Medicine•2018•Cited by: 2•References: 22

  • Mitigating regulatory impact

    Open Access•Ajay Bhaskarabhatla, Chirantan Chatterjee et al.•ARTICLE•Health Policy and Planning•2016•Cited by: 1•References: 32

    The use of drug price controls is a contentious issue globally. Low- and middle-income countries use direct price controls to improve access to essential drugs. But such price controls have little meaning if they are not designed and implemented well, and the extent to which firms coordinate in these countries to weaken price controls has been largely overlooked. In mid-2013, India adopted partial price-cap regulation for some, but not all, formu…

  • Women’s Disempowerment and Preferences for Skin Lightening Products That Reinforce Colorism

    Open Access•Arzi Adbi, Chirantan Chatterjee et al.•ARTICLE•Psychology of Women Quarterly•2021•Cited by: 6•References: 15

    Global racism and colorism, the preference for fairer skin even within ethnic and racial groups, leads millions of women of African, Asian, and Latin descent to use products with chemical ingredients intended to lighten skin color. Drawing from literatures on the impact of chronic and situational disempowerment on behavioral risk-taking to enhance status, we hypothesized that activating feelings of disempowerment would increase women of color’s i…

  • Government health insurance and spatial peer effects

    Open Access•Chirantan Chatterjee, Radhika Joshi et al.•ARTICLE•Social Science & Medicine•2018•Cited by: 2•References: 22

  • Intellectual property regimes and wage inequality

    Open Access•Sourav Bhattacharya, Pavel Chakraborty et al.•ARTICLE•Journal of Development Economics•2021•Cited by: 1•References: 8

  • From courts to markets

    Open Access•Chirantan Chatterjee, Debi Prasad Mohapatra et al.•ARTICLE•Social Science & Medicine•2019•Cited by: 1•References: 25

  • Mitigating regulatory impact

    Open Access•Ajay Bhaskarabhatla, Chirantan Chatterjee et al.•ARTICLE•Health Policy and Planning•2016•Cited by: 1•References: 32

    The use of drug price controls is a contentious issue globally. Low- and middle-income countries use direct price controls to improve access to essential drugs. But such price controls have little meaning if they are not designed and implemented well, and the extent to which firms coordinate in these countries to weaken price controls has been largely overlooked. In mid-2013, India adopted partial price-cap regulation for some, but not all, formu…

  • Mitigating regulatory impact

    Open Access•Ajay Bhaskarabhatla, Chirantan Chatterjee et al.•ARTICLE•Health Policy and Planning•2016•Cited by: 1•References: 32

    The use of drug price controls is a contentious issue globally. Low- and middle-income countries use direct price controls to improve access to essential drugs. But such price controls have little meaning if they are not designed and implemented well, and the extent to which firms coordinate in these countries to weaken price controls has been largely overlooked. In mid-2013, India adopted partial price-cap regulation for some, but not all, formu…

  • Government health insurance and spatial peer effects

    Open Access•Chirantan Chatterjee, Radhika Joshi et al.•ARTICLE•Social Science & Medicine•2018•Cited by: 2•References: 22

  • From courts to markets

    Open Access•Chirantan Chatterjee, Debi Prasad Mohapatra et al.•ARTICLE•Social Science & Medicine•2019•Cited by: 1•References: 25

  • Did India's price control policy for coronary stents create unintended consequences

    Open Access•Sarang Deo, Hanu Tyagi et al.•ARTICLE•Social Science & Medicine•2020•References: 24

  • Women’s Disempowerment and Preferences for Skin Lightening Products That Reinforce Colorism

    Open Access•Arzi Adbi, Chirantan Chatterjee et al.•ARTICLE•Psychology of Women Quarterly•2021•Cited by: 6•References: 15

    Global racism and colorism, the preference for fairer skin even within ethnic and racial groups, leads millions of women of African, Asian, and Latin descent to use products with chemical ingredients intended to lighten skin color. Drawing from literatures on the impact of chronic and situational disempowerment on behavioral risk-taking to enhance status, we hypothesized that activating feelings of disempowerment would increase women of color’s i…

  • Intellectual property regimes and wage inequality

    Open Access•Sourav Bhattacharya, Pavel Chakraborty et al.•ARTICLE•Journal of Development Economics•2021•Cited by: 1•References: 8

  • Did the Covid-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data

    Open Access•Sawan Rathi, Adrija Majumdar et al.•ARTICLE•Technological Forecasting and…•2024

    It is now much discussed that Artificial Intelligence (AI) as a General-Purpose Technology (GPT) can resolve the efficiency problems of industries, including in pharmaceutical markets where productivity challenges continue in costs and time for new drug discovery. But did the COVID-19 pandemic inadvertently accelerate the pace of AI adoption in pharmaceutical innovation? We answer this question using novel data on pharmaceutical patents. We use t…

Business (6 works) · Economics (6 works) · Medicine (5 works) · Economic growth (3 works) · Intellectual Property and Patents (3 works) · Context (archaeology (2 works) · Finance (2 works) · Firm Innovation and Growth (2 works) · Geography (2 works) · Health care (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae